Morgan Stanley’s IB Acquisition Corp IBAC Stock Holding History

Morgan Stanley’s Portfolio IBAC Stock Details IBAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$485	Sell	45 -6	-12%	-$65	﹤0.01%	7670
2026 Q1	$544	Sell	51 -11	-18%	-$117	﹤0.01%	7602
2025 Q4	$651	Buy	62 +42	+210%	+$439	﹤0.01%	7455
2025 Q3	$210	Sell	20 -44	-69%	-$463	﹤0.01%	7594
2025 Q2	$668	Buy	64 +48	+300%	+$499	﹤0.01%	7383
2025 Q1	$165	Buy	+16	New	+$164	﹤0.01%	7493

Other funds holding IBAC

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Morgan Stanley's IBAC Position: Q2 2026 in Review

Morgan Stanley reduced its IB Acquisition Corp (IBAC) stake by 12% in Q2 2026, selling an estimated $65 and leaving 45 shares worth $485. The position accounts for ﹤0.01% of the portfolio, ranked #7670.

Morgan Stanley first reported a position in IBAC in Q1 2025 and has held it in 6 quarters since. The position peaked at $668 in Q2 2025. 5 funds tracked by Wall St. Rank hold IBAC as of Q2 2026.

Morgan Stanley held 45 shares of IB Acquisition Corp worth $485 as of Q2 2026.
Morgan Stanley sold 6 IB Acquisition Corp shares in Q2 2026, an estimated $65.
IB Acquisition Corp made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7670 holding.
Morgan Stanley first reported a position in IB Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
Morgan Stanley's IB Acquisition Corp position peaked at $668 in Q2 2025.
5 funds tracked by Wall St. Rank held IB Acquisition Corp as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.